1-20 of 115
Qaiser Bashir, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma

Aimaz Afrough, MD, Leonard C Alsfeld, MD, Ruby Delgado, Uday R. Popat, MD, Partow Kebriaei, MD, Betul Oran, MDMS, Neeraj Saini, MD, Samer A. Srour, MD MS, Chitra Hosing, MD, Elisabet E. Manasanch, MD, Hans C. Lee, MD, Gregory P. Kaufman, MD, Krina K. Patel, MD, Robert Z. Orlowski, MDPhD, Chelsea C. Pinnix, MD PhD, Bouthaina S. Dabaja, MD, Sheeba K. Thomas, MD, Donna M. Weber, MD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD, Qaiser Bashir, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22.
https://doi.org/10.1182/blood-2020-141261
Published: 2020
Journal Articles

Outcomes in Patients with AL (Light-Chain) Cardiac Amyloidosis

Jeremy L. Ramdial, MD, Mahmoud R. Gaballa, MD, Taha Al-Juhaishi, MD, Qaiser Bashir, MD, Samer A. Srour, MD MS, Neeraj Saini, MD, Yago Nieto, MD, Chitra Hosing, MD, Uday R. Popat, MD, Regan Murphy, PA-C, Hans C. Lee, MD, Krina K. Patel, MD, Elisabet E. Manasanch, MD, Sheeba K. Thomas, MD, Donna M. Weber, MD, Gregory P. Kaufman, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–13.
https://doi.org/10.1182/blood-2020-143209
Published: 2020
Journal Articles

Nonmyeloablative Allogeneic Stem Cell Transplantation with or without Inotuzumab Ozogamicin for Lymphoid Malignancies

Issa F. Khouri, MD, Stephen K. Gruschkus, PhD MPH, Alison Gulbis, Celina Ledesma, Nitin Jain, MD, Tapan M. Kadia, MD, Naveen Pemmaraju, MD, Paolo Anderlini, Qaiser Bashir, MD, May Daher, Partow Kebriaei, MD, David Marin, Rohtesh Mehta, Uday R. Popat, MD, Neeraj Saini, MD, Samer A. Srour, MD MS, Jin S. Im, Luis Fayad, Ranjit Nair, MD, Swaminathan P Iyer, MD, Paolo Strati, MD, Felipe Samaniego, MD, Loretta J. Nastoupil, MD, Christopher Flowers, MDMS, Gabriela Rondon, Hagop M. Kantarjian, MD, Richard E. Champlin, MD, Elias Jabbour, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–12.
https://doi.org/10.1182/blood-2020-141985
Published: 2020
Journal Articles

Trial in Progress: A Prospective Phase I/II Trial to Jointly Optimize the Administration Schedule(s) and Dose(s) of Melphalan for Injection (Evomela) As a Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma

Qaiser Bashir, MD, Peter F Thall, PhD, Dawen Sui, Cristina Knape, Jitesh Kawedia, BPharm, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-139853
Published: 2020
Journal Articles

Long-Term Survival for Myeloma after Autologous Stem Cell Transplantation

Samer A. Srour, MD MS, Qaiser Bashir, MD, Denái R. Milton, MS, Yago Nieto, MD, Rohtesh S. Mehta, MDMPH,MS, Neeraj Saini, MD, Ruby Delgado, Gabriela Rondon, Stefan O. Ciurea, MD, Uday R. Popat, MD, Issa F. Khouri, MD, Partow Kebriaei, MD, Elisabet E. Manasanch, MD, Chitra Hosing, MD, Krina K. Patel, MD, Hans C. Lee, MD, Elizabeth J. Shpall, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-143053
Published: 2020
Journal Articles

Survival Trends in Multiple Myeloma after Autologous Hematopoietic Stem Cell Transplantation

Samer A. Srour, MD MS, Qaiser Bashir, MD, Denái R. Milton, MS, Yago Nieto, MD, Rohtesh S. Mehta, MDMPH,MS, Neeraj Saini, MD, Ruby Delgado, Gabriela Rondon, Chitra Hosing, MD, Stefan O. Ciurea, MD, May Daher, Uday R. Popat, MD, Issa F. Khouri, MD, Partow Kebriaei, MD, Elisabet E. Manasanch, MD, Gregory P. Kaufman, MD, Krina K. Patel, MD, Elizabeth J. Shpall, MD, Hans C. Lee, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-143196
Published: 2020
Journal Articles

Outcomes of Patients with Multiple Myeloma Who Received VRD Induction, Autologous Hematopoietic Cell Transplantation and Lenalidomide Maintenance

Mahmoud R. Gaballa, MD, Taha Al-Juhaishi, MD, Qaiser Bashir, MD, Samer A. Srour, MD MS, Neeraj Saini, MD, Jeremy Ramdial, MD, Yago Nieto, MD, Regan Murphy, PA-C, Hans C. Lee, MD, Krina K. Patel, MD, Partow Kebriaei, MD, Sheeba K. Thomas, MD, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–15.
https://doi.org/10.1182/blood-2020-135865
Published: 2020
Journal Articles

Extensive Changes of the Immune Microenvironment Are Associated with Progression from Precursor Stages to Multiple Myeloma

Elisabet E. Manasanch, MD, Guangchun Han, Zheng Zhang, Minghao Dang, Manisha Singh, Maliha Khan, MD, Shubhra Singh, Hans C. Lee, MD, Krina K. Patel, MD, Gregory P. Kaufman, MD, Behrang Amini, MD PhD, Qaiser Bashir, MD, Samer A. Srour, MD MS, Yago Nieto, MD, Muzaffar H. Qazilbash, MD, Zuzana Berkova, PhD, Pei Lin, MDDM,MDC, Donald Berry, MD PhD, Sheeba K. Thomas, MD, Donna M. Weber, MD, P. Andrew Futreal, Linghua Wang, PhD, Robert Z. Orlowski, MDPhD, Sattva S. Neelapu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-137555
Published: 2020
Journal Articles

Phase 2 Study of Tagraxofusp Therapy for BPDCN Patients Post-Autologous or Post-Allogeneic Hematopoietic Cell Transplantation

Qaiser Bashir, MD, Katayoun Rezvani, MD PhD, Neeraj Saini, MD, Elizabeth J. Shpall, MD, Samer A. Srour, MD MS, Uday R. Popat, MD, Denái R. Milton, MS, Naveen Pemmaraju, MD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5.
https://doi.org/10.1182/blood-2020-137207
Published: 2020
Journal Articles

A Randomized Study of Pretransplant Conditioning Therapy for AML/MDS with Fludarabine ± Clofarabine and Once Daily IV Busulfan with Allogeneic Hematopoietic Transplantation for AML and MDS

Borje S. Andersson, MD, PhD, Peter Thall, Benigno C. Valdez, PhD, Junsheng Ma, MS, Julianne Chen, Sairah Ahmed, MD, Amin M. Alousi, MD, Qaiser Bashir, MD, Stefan O. Ciurea, MD, Alison Gulbis, Chitra Hosing, MD, Roy B. Jones, MD PhD, Jitesh Kawedia, BPharm, Partow Kebriaei, MD, Steven M. Kornblau, MD, Alan Myers, PharmD, PhD RPh, Betul Oran, MDMS, Katayoun Rezvani, MD PhD, Nina Shah, MD, Elizabeth J. Shpall, MD, Simrit Parmar, MD, MSCI, Uday R. Popat, MD, Yago Nieto, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-142680
Published: 2020
Journal Articles

Update of a Phase II Study of Lenalidomide-Elotuzumab As Maintenance Therapy Post-Autologous Stem Cell Transplant (AuSCT) in Patients (Pts) with Multiple Myeloma (MM)

Sheeba K. Thomas, MD, Jatin J. Shah, MD, Armando Morin, M.A., Ashley N. Morphey, M.S.N., Hans C. Lee, MD, Elisabet E. Manasanch, MD, Krina K. Patel, MD, Gregory P. Kaufman, MD, Swami P. Iyer, MD, Lei Feng, MS, Behrang Amini, MD PhD, Muzaffar H. Qazilbash, MD, Qaiser Bashir, MD, Neeraj Saini, MD, Samer A. Srour, MD MS, Ralph J. Johnson, PhD, Brandon N. Crumpton, Mildred D. Stafford, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-139934
Published: 2020
Journal Articles

African-Americans Multiple-Myeloma Patients Undergoing Upfront Autologous Stem Cell Transplant Have Similar Survival Outcomes Compared to Whites: A Propensity-Score Matched Analysis

Neeraj Saini, MD, Junsheng Ma, MS, Qaiser Bashir, MD, Ruby Delgado, Gabriela Rondon, Uday R. Popat, MD, Chitra Hosing, MD, Yago Nieto, MD, Partow Kebriaei, MD, Amin M. Alousi, MD, Rohtesh S. Mehta, MDMPH,MS, Samer A. Srour, MD MS, Issa F. Khouri, MD, Donna M. Weber, MD, Sheeba K. Thomas, MD, Hans C. Lee, MD, Krina K. Patel, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–10.
https://doi.org/10.1182/blood-2020-134837
Published: 2020
Journal Articles

Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with t(11;14) Undergoing Autologous Hematopoietic Stem Cell Transplantation

Aimaz Afrough, MD, Leonard C Alsfeld, MD, Samer A. Srour, MD MS, Qaiser Bashir, MD, Neeraj Saini, MD, Chitra Hosing, MD, Uday R. Popat, MD, Partow Kebriaei, MD, Elizabeth J. Shpall, MD, Ruby Delgado, Regan Murphy, PA-C, Elisabet E. Manasanch, MD, Hans C. Lee, MD, Gregory P. Kaufman, MD, Krina K. Patel, MD, Sheeba K. Thomas, MD, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–19.
https://doi.org/10.1182/blood-2020-141307
Published: 2020
Journal Articles

Prognostic Impact of Beta 2 Microglobulin in Patients with Immunoglobulin Light-Chain Amyloidosis Undergoing Autologous Hematopoietic Stem Cell Transplantation

Aimaz Afrough, MD, Samer A. Srour, MD MS, Qaiser Bashir, MD, Neeraj Saini, MD, Chitra Hosing, MD, Uday R. Popat, MD, Partow Kebriaei, MD, Elizabeth J. Shpall, MD, Ruby Delgado, Regan Murphy, PA-C, Elisabet E. Manasanch, MD, Hans C. Lee, MD, Gregory P. Kaufman, MD, Krina K. Patel, MD, Sheeba K. Thomas, MD, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-141360
Published: 2020
Journal Articles

Myeloablative Fractionated Busulfan with Fludarabine in Older Patients: Long Term Outcomes of Prospective Phase II Clinical Trial

Rohtesh S. Mehta, MDMPH,MS, Roland Bassett, Julianne Chen, Benigno C. Valdez, PhD, Jitesh Kawedia, BPharm, Amin M. Alousi, MD, Gheath Alatrash, Qaiser Bashir, MD, Stefan Ciurea, MD, Chitra Hosing, MD, Jin S. Im, Partow Kebriaei, MD, Amanda L. Olson, Betul Oran, MDMS, Muzaffar H. Qazilbash, MD, Samer A. Srour, MD MS, Elizabeth J. Shpall, MD, Borje S. Andersson, MD, PhD, Richard E. Champlin, MD, Uday R. Popat, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-139325
Published: 2020
Journal Articles

PBSC Mobilization for Auto-HSCT in Myeloma: Growth Factors Vs Growth Factors + Chemotherapy

Jeremy L. Ramdial, MD, Junsheng Ma, MS, Denai R. Milton, MS, Ruby Delgado, Qaiser Bashir, MD, Samer A. Srour, MD MS, Neeraj Saini, MD, Yago Nieto, MD, Chitra Hosing, MD, Uday R. Popat, MD, Regan Murphy, PA-C, Hans C. Lee, MD, Krina K. Patel, MD, Elisabet E. Manasanch, MD, Sheeba K. Thomas, MD, Gregory P. Kaufman, MD, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD, Richard E. Champlin, MD, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-143108
Published: 2020
Journal Articles

Timed Sequential Busulfan and Post-Transplantation Cyclophosphamide in Matched and Haploidentical Transplantation: Results of a Phase II Study

Uday Popat, MD, Rohtesh S. Mehta, MD MPH, MS, Roland L. Bassett, Jr., Amanda L. Olson, MD, Julianne Chen, Sairah Ahmed, MD, Amin M. Alousi, MD, Paolo Anderlini, MD, Gheath Alatrash, DO, PhD, Qaiser Bashir, MD MBBS, Stefan O. Ciurea, Chitra Hosing, MD, Jin S Im, MD PhD, Partow Kebriaei, MD, Issa F. Khouri, David Marin, MD, Yago Nieto, MD PhD, Betul Oran, MDMS, Katy Rezvani, MD PhD, Muzaffar H. Qazilbash, MD, Elizabeth J. Shpall, MD, Richard E Champlin, MD, Borje S Andersson, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3373.
https://doi.org/10.1182/blood-2018-99-113439
Published: 2018
Journal Articles

Safety Analysis of Intra-Patient Dose- Study of Crenolanib Maintenance Therapy in Patients with FLT3 Mutant AML Following Allogeneic Hematopoietic Stem Cell Transplant

Betul Oran, MDMS, Stefan O. Ciurea, David Marin, MD, Jessica M McCarty, Qaiser Bashir, MD MBBS, Sairah Ahmed, MD, Amanda L. Olson, MD, Uday Popat, MD, Yago Nieto, MD PhD, Partow Kebriaei, MD, Elizabeth J. Shpall, MD, Trishala Agrawal, MD, Richard E Champlin, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3426.
https://doi.org/10.1182/blood-2018-99-119390
Published: 2018
Journal Articles

Allogeneic Transplantation for Lymphoid Malignancies with Fludarabine and Melphalan Conditioning and Different Donor Types

Neeraj Y Saini, MD, Rima M. Saliba, PhD, Gabriela Rondon, MD, Farzaneh Maadani, Uday Popat, MD, Betul Oran, MD MS, Chitra Hosing, MD, Qaiser Bashir, MD MBBS, Amanda L. Olson, MD, Yago Nieto, MD PhD, Amin M. Alousi, MD, Partow Kebriaei, MD, Samer A. Srour, MD, Rohtesh S. Mehta, MD MPH, MS, Paolo Anderlini, MD, Elizabeth J. Shpall, MD, Muzaffar H. Qazilbash, MD, Issa F. Khouri, Luis E. Fayad, Hun Ju Lee, MD, Nathan H. Fowler, MD, Simrit Parmar, MBBS, Jason R. Westin, MD, F. B. Hagemeister, MD, Richard E Champlin, MD, Stefan O. Ciurea
Journal: Blood
Blood (2018) 132 (Supplement 1): 3356.
https://doi.org/10.1182/blood-2018-99-117039
Published: 2018
Journal Articles

Is a Matched Unrelated Donor Search Needed for All Allogeneic Transplant Candidates?

Stefan O. Ciurea, Maria Cecilia Borges Bittencourt, MD, Denái R. Milton, Kai Cao, MS, MD, Piyanuch Kongtim, MD, Gabriela Rondon, MD, Julianne Chen, Marina Y. Konopleva, MD PhD, Jorge M. Ramos Perez, Mohammed Elshazly, MD MSc, Majdi Aljadayeh, MD, Michele Alvarez, Jin S Im, MD PhD, Gheath Alatrash, DO, PhD, Rohtesh S. Mehta, MD MPH, MS, Uday Popat, MD, Qaiser Bashir, MD MBBS, Betul Oran, MD MS, Chitra Hosing, MD, Issa F. Khouri, Partow Kebriaei, MD, Richard E Champlin, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3450.
https://doi.org/10.1182/blood-2018-99-111606
Published: 2018